United States · Law · S
S. 622 (113th)
Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Introduced
20 March 2013
Last action
—
Status
Became Public Law No: 113-14.
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 - Animal Drug User Fee Amendments of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to extend for FY2014-FY2018 the authority of the Food and Drug Administration (FDA) to collect animal drug user fees, specifically new animal drug application or supplemental animal drug application fees, animal drug product fees, animal drug establishment fees, and animal drug sponsor fees. Revises the due date for annual user fees to the later of January 31 of each year or the first business day after enactment of an appropriations act providing for the collection and obligation of fees for the fiscal year. Establishes the amount of revenue such fees can generate. Specifies percentages of the total revenue that shall be derived from each type of user fee. Requires the Secretary of Health and Human Services (HHS) to adjust the total revenue amounts for FY2015 and subsequent fiscal year for inflation. Authorizes the Secretary to accept payment of user fees prior to their due date. Requires the total fees collected for FY2016-FY2018 to be increased by the cumulative amount, if any, by which the amount of user fees collected and appropriated for prior fiscal year falls below the cumulative amount of fees authorized. Terminates the authority to collect user fees October 1, 2018. Animal Generic Drug User Fee Amendments of 2013 - Extends for FY2014-FY2018 the authority of the FDA to collect generic animal drug user fees, specifically abbreviated application fees for generic new animal drugs, generic new animal drug product fees, and generic new animal drug sponsor fees. Revises the due date for annual generic animal drug user fees to the later of January 31 of each year or the first business day after enactment of an appropriations act providing for the collection and obligation of fees for the fiscal year. Establishes the total amount of revenue each type of generic user fee shall generate. Authorizes the Secretary to accept payment of user fees prior to their due date. Terminates the authority to collect generic animal drug user fees October 1, 2018.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
13 official files
Enrolled Bill (text)
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
Public Law (text)
Public Law · EN · 14 June 2013
Public Law (PDF)
Public Law · EN · 14 June 2013
Public Law
summary · EN · 13 June 2013
Passed House without amendment
summary · EN · 3 June 2013
Engrossed in Senate (text)
Engrossed in Senate · EN · 8 May 2013
Engrossed in Senate (PDF)
Engrossed in Senate · EN · 8 May 2013
Passed Senate without amendment
summary · EN · 8 May 2013
Placed on Calendar Senate (text)
Placed on Calendar Senate · EN · 20 March 2013
Placed on Calendar Senate (PDF)
Placed on Calendar Senate · EN · 20 March 2013
Reported to Senate without amendment
summary · EN · 20 March 2013
Introduced in Senate
summary · EN · 20 March 2013
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/senate-bill/622
- Open data entity: https://api.congress.gov/v3/bill/113/s/622